Childhood Chronic Immune Thrombocytopenic Purpura: Unresolved Issues

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue SUPPL. 1, 2003, Pages

  Blanchette, Victor S ^a   Price, Victoria ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Children; Chronic ITP; Immune thrombocytopenic purpura; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANTIBIOTIC AGENT; ASCORBIC ACID; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DANAZOL; DAPSONE; DEXAMETHASONE; ETOPOSIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; MERCAPTOPURINE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD20; PENICILLIN G; PNEUMOCOCCUS VACCINE; PREDNISONE; PROCARBAZINE; RHESUS D ANTIBODY; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; AUTOIMMUNE DISEASE; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DRUG CONTRAINDICATION; HEALTH CARE COST; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNIZATION; IRRITABILITY; LAPAROSCOPIC SURGERY; MONOTHERAPY; MOOD DISORDER; POSTOPERATIVE CARE; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SLEEP DISORDER; SPLENECTOMY; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE; TREATMENT INDICATION;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; EMERGENCIES; FEMALE; HUMANS; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 0344304491     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200312001-00007     Document Type: Conference Paper

References (46)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346(13):995-1008.
2. Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol. 1992;29: 72-82.
3. Simons SM, Main CA, Yaish HM, et al. Idiopathic thrombocytopenic purpura in children. J Pediatr. 1975;87:16-22.
4. Robb LG, Tiedeman K. Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Child. 1990;65:502-506.
5. Reid MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child. 1995;72:125-128.
6. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
7. Imbach P, Akatsuka J, Blanchette V, et al. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr. 1995;154:S60-S64.
8. Carcao MD, Zipursky A, Butchart S, et al. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998;424:71-74.
9. Bussel JB, Schulman I, Hilgartner MW, et al. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J Pediatr. 1983;103:651-654.
10. Andrew M, Blanchette VS, Adams M, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr. 1992;120:522-527.
11. Scaradavou A, Woo B, Woloski BM, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood. 1997;89:2689-2700.
12. Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 μg/kg/day of IV anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/day in adults with immune thrombocytopenic purpura. Br J Haem. 2001;112(4):1076-1078.
13. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med. 1994;330: 1560-1564.
14. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child. 1992;67:1056-1058.
15. Working Party of the British Committee for Standards in Haematology. General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574-596.
16. Park A, Heniford BT, Hebra A, et al. Pediatric laparoscopic splenectomy. Surg Endosc. 2000;14:527-531.
17. Szold A, Schwartz J, Abu-Abeid S, et al. Laparoscopic splenectomies for idiopathic thrombocytopenic purpura: experience of sixty cases. Am J Hematol. 2000;63:7-10.
18. Ben Yehuda D, Gillis S, Eldor A. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol. 1994;91:1-6.
19. Mantadakis E, Buchanan GR. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2000;22: 148-153.
20. Monpoux F, Kurzenne JY, Sirvent N, et al. Partial splenectomy in a child with human immunodeficiency virus-related immune thrombocytopenia. J Pediatr Hematol Oncol. 1999;21:441-443.
21. Najean Y, Rain JD, Billotey C. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol. 1997;97:547-550.
22. Holt D, Brown J, Terrill K, et al. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics. 2003;111:87-90.
23. Bussel JB, Kaufmann CP, Ware RE, et al. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol. 2001;67:27-33.
24. Advisory Committee on Immunization Practices (ACIP). Recommendations: Use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep. 1993;42:1-18.
25. Committee on Infectious Diseases. American Academy of Pediatrics. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
26. Infectious Diseases and Immunization Committee. Canadian Pediatric Society. Prevention and therapy of bacterial infections for children with asplenia or hyposplenia. Pediatr Child Health. 1999;4:417-421.
27. Blanchette V, Freedman J, Garvey B. Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol. 1998; 35:36-51.
28. Scaradavou A, Bussel J. Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol. J Pediatr Hematol Oncol. 1995;17:290-295.
29. Williams JA, Boxer LA. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents. J Pediatr Hematol Oncol. 2003;25:232-235.
30. Figueroa M, Gehlsen J, Hammond D, et al. Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med. 1993;328: 1226-1229.
31. van Hoff J, Ritchey AK. Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. J Pediatr. 1988; 113: 563-566.
32. Baumann MA, Menitove JE, Aster RH, et al. Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Intern Med. 1986;104:808-809.
33. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr. 2002;141:683-688.
34. Bamard D, Woloski M, Feeny D, et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003;25:56-62.
35. Ramos ME, Newman AJ, Gross S. Chronic thrombocytopenia in childhood. J Pediatr. 1978;92:584-586.
36. Hoyle C, Darbyshire P, Eden OB. Idiopathic thrombocytopenia in childhood. Edinburgh experience 1962-82. Scott Med J. 1986;31:174-179.
37. Tamary H, Kaplinsky C, Levy I, et al. Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up. Acta Paediatr. 1994;83: 931-934.
38. Yetgin S, Olcay L, Ozsoylu S, et al. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol. 1997;14:399-412.
39. Aronis S, Platokouki H, Mitsika A, et al. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol. 1994;11:487-498.
40. Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr. 2002;141:253-258.
41. Wong MS, Chan GC, Ha SY, et al. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children. J Pediatr Hematol Oncol. 2002;24:648-652.
42. Kühne T, Freedman J, Semple JW, et al. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr. 1997;130:17-24.
43. Borgna-Pignatti C, Rugolotto S, Nobili B, et al. A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr. 1997;130:13-16.
44. Chen JS, Wu JM, Chen YJ, et al. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 1997;19:526-529.
45. Wali YA, Al Lamki Z, Shah W, et al. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 2002;19:329-335.
46. Hedlund-Treutiger I, Henter JI, Elinder G. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25: 139-144.